{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:54:59Z","timestamp":1775044499534,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1746-1596-6-126","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T07:16:25Z","timestamp":1324538185000},"source":"Crossref","is-referenced-by-count":36,"title":["Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China"],"prefix":"10.1186","volume":"6","author":[{"given":"Qingbin","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangmin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,21]]},"reference":[{"key":"498_CR1","first-page":"94","volume-title":"Diagnostic Pathology and Molecular Genetics of the Thyroid","author":"YE Nikiforov","year":"2009","unstructured":"Nikiforov YE: Thyroid tumors: classification and general considerations. Diagnostic Pathology and Molecular Genetics of the Thyroid. Edited by: Nikiforov YE, Biddinger PW, Thompson LDR. 2009, Lippincott Williams & Wilkins, Baltimore, MA, 94-102."},{"key":"498_CR2","first-page":"1674","volume-title":"Lippincott Williams & Wilkins","author":"VT DeVita","year":"2008","unstructured":"DeVita VT, Hellman JS, Rosenberg SA: Cancer: principles and practice of oncology. Lippincott Williams & Wilkins. 2008, 1674-1699."},{"key":"498_CR3","first-page":"341","volume":"8","author":"K Sethi","year":"2010","unstructured":"Sethi K, Sarkar S, Das S, Mohanty B, Mandal M: Biomarkers for the diagnosis of thyroid cancer. J Exp Ther Oncol. 2010, 8: 341-352.","journal-title":"J Exp Ther Oncol"},{"key":"498_CR4","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.suc.2009.06.012","volume":"89","author":"MA Kato","year":"2009","unstructured":"Kato MA, Fahey TJ: Molecular markers in thyroid cancer diagnostics. Surg Clin North Am. 2009, 89: 1139-1155. 10.1016\/j.suc.2009.06.012.","journal-title":"Surg Clin North Am"},{"key":"498_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/modpathol.2010.167","volume":"2","author":"YE Nikiforov","year":"2011","unstructured":"Nikiforov YE: Molecular analysis of thyroid tumors. Mod Pathol Suppl. 2011, 2: 34-43.","journal-title":"Mod Pathol Suppl"},{"key":"498_CR6","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s00268-010-0746-3","volume":"34","author":"Y Ito","year":"2010","unstructured":"Ito Y, Miyauchi A, Kakudo K, Hirokawa M, Kobayashi K, Miya A: Prognostic significance of ki-67 labeling index in papillary thyroid carcinoma. World J Surg. 2010, 34: 3015-21. 10.1007\/s00268-010-0746-3.","journal-title":"World J Surg"},{"key":"498_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1755-8794-4-30","volume":"6;4","author":"K Vierlinger","year":"2011","unstructured":"Vierlinger K, Mansfeld MH, Koperek O, N\u00f6hammer C, Kaserer K, Leisch F: Identification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation. BMC Med Genomics. 2011, 6;4: 30-","journal-title":"BMC Med Genomics"},{"key":"498_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.anndiagpath.2010.11.005","volume":"15","author":"A Tan","year":"2011","unstructured":"Tan A, Etit D, Bayol U, Altinel D, Tan S: Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma. Ann Diagn Pathol. 2011, 15: 108-116. 10.1016\/j.anndiagpath.2010.11.005.","journal-title":"Ann Diagn Pathol"},{"key":"498_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000093056","volume":"27","author":"M Frykn\u00e4s","year":"2006","unstructured":"Frykn\u00e4s M, Wickenberg-Bolin U, G\u00f6ransson H, Gustafsson MG, Foukakis T, Lee JJ, Landegren U, H\u00f6\u00f6g A, Larsson C, Grimelius L, Wallin G, Pettersson U, Isaksson A: Molecular markers for discrimination of benign and malignant follicular thyroid tumors. Tumour Biol. 2006, 27: 211-220. 10.1159\/000093056.","journal-title":"Tumour Biol"},{"key":"498_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/thy.2010.0173","volume":"21","author":"G Magro","year":"2011","unstructured":"Magro G, Cataldo I, Amico P, Torrisi A, Vecchio GM, Parenti R, Asioli S, Recupero D, D'Agata V, Mucignat MT, Perris R: Aberrant expression of TfR1\/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target. Thyroid. 2011, 21: 267-277. 10.1089\/thy.2010.0173.","journal-title":"Thyroid"},{"key":"498_CR11","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.2353\/ajpath.2010.090353","volume":"176","author":"CG Chiu","year":"2010","unstructured":"Chiu CG, Strugnell SS, Griffith OL, Jones SJ, Gown AM, Walker B, Nabi IR, Wiseman SM: Diagnostic utility of galectin-3 in thyroid cancer. Am J Pathol. 2010, 176: 2067-2081. 10.2353\/ajpath.2010.090353.","journal-title":"Am J Pathol"},{"key":"498_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12022-010-9114-y","volume":"21","author":"F Barut","year":"2010","unstructured":"Barut F, Onak Kandemir N, Bektas S, Bahadir B, Keser S, Ozdamar SO: Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19. Endocr Pathol. 2010, 21: 80-89. 10.1007\/s12022-010-9114-y.","journal-title":"Endocr Pathol"},{"key":"498_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3346\/jkms.2007.22.4.621","volume":"22","author":"YJ Park","year":"2007","unstructured":"Park YJ, Kwak SH, Kim DC, Kim H, Choe G, Park do J, Jang HC, Park SH, Cho BY, Park SY: Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27 (kip1) in the differential diagnosis of thyroid nodules. J Korean Med Sci. 2007, 22: 621-628. 10.3346\/jkms.2007.22.4.621.","journal-title":"J Korean Med Sci"},{"key":"498_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1746-1596-3-5","volume":"3","author":"D El Demellawy","year":"2008","unstructured":"El Demellawy D, Nasr A, Alowami S: Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid. Diagn Pathol. 2008, 3: 5-10.1186\/1746-1596-3-5.","journal-title":"Diagn Pathol"},{"key":"498_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/modpathol.3800235","volume":"18","author":"ML Prasad","year":"2005","unstructured":"Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, de la Chapelle A, Kloos RT: Galectin-3, fibronectin-1, CITED-1, HBME-1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol. 2005, 18: 48-57. 10.1038\/modpathol.3800235.","journal-title":"Mod Pathol"},{"key":"498_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2559.2005.02221.x","volume":"47","author":"PS de Matos","year":"2005","unstructured":"de Matos PS, Ferreira AP, de Oliveira Facuri F, Assump\u00e7\u00e3o LV, Metze K, Ward LS: Usefulness of HBME-1, cytokeratin-19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology. 2005, 47: 391-401. 10.1111\/j.1365-2559.2005.02221.x.","journal-title":"Histopathology"},{"key":"498_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/path.1711680404","volume":"168","author":"G Cattoretti","year":"1992","unstructured":"Cattoretti G, Becker MH, Key G, Duchrow M, Schl\u00fcter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed for malin-fixed paraffin sections. J Pathol. 1992, 168: 357-363. 10.1002\/path.1711680404.","journal-title":"J Pathol"},{"key":"498_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/path.1185","volume":"198","author":"AD Saiz","year":"2002","unstructured":"Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK: Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions. J Pathol. 2002, 198: 157-162. 10.1002\/path.1185.","journal-title":"J Pathol"},{"key":"498_CR19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1177\/147323000903700339","volume":"37","author":"HS Liang","year":"2009","unstructured":"Liang HS, Zhong YH, Luo ZJ, Huang Y, Lin HD, Luo M, S-Zhan Su HX, Zhou SB, Xie KQ: Comparative analysis of protein expression in differentiated thyroid tumours: a multicentre study. J Int Med Res. 2009, 37: 927-938.","journal-title":"J Int Med Res"},{"key":"498_CR20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/jcp.22187","volume":"224","author":"A Carpi","year":"2010","unstructured":"Carpi A, Mechanick JI, Saussez S, Nicolini A: Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications. J Cell Physiol. 2010, 224: 612-619. 10.1002\/jcp.22187.","journal-title":"J Cell Physiol"},{"key":"498_CR21","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1210\/jc.84.9.3228","volume":"84","author":"V Lazar","year":"1999","unstructured":"Lazar V, Bidart JM, Caillou B, Mah\u00e9 C, Lacroix L, Filetti S, Schlumberger M: Expression of the Na+\/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab. 1999, 84: 3228-3234. 10.1210\/jc.84.9.3228.","journal-title":"J Clin Endocrinol Metab"},{"key":"498_CR22","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1210\/jc.2002-020094","volume":"87","author":"L Martins","year":"2002","unstructured":"Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET: Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab. 2002, 87: 4806-4810. 10.1210\/jc.2002-020094.","journal-title":"J Clin Endocrinol Metab"},{"key":"498_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s003359900548","volume":"8","author":"J Raimond","year":"1997","unstructured":"Raimond J, Zimonjic DB, Mignon C, Mattei M, Popescu NC, Monsigny M, Legrand A: Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22. Mamm Genome. 1997, 8: 706-707. 10.1007\/s003359900548.","journal-title":"Mamm Genome"},{"key":"498_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12022-008-9033-3","volume":"19","author":"HK T\u00fcrk\u00f6z","year":"2008","unstructured":"T\u00fcrk\u00f6z HK, Oks\u00fcz H, Yurdakul Z, Ozcan D: Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma. Endocr Pathol. 2008, 19: 92-96. 10.1007\/s12022-008-9033-3.","journal-title":"Endocr Pathol"},{"key":"498_CR25","first-page":"3015","volume":"58","author":"F Orlandi","year":"1998","unstructured":"Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A: Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res. 1998, 58: 3015-3020.","journal-title":"Cancer Res"},{"key":"498_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1053\/hp.2000.6534","volume":"31","author":"K Kawachi","year":"2000","unstructured":"Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, Natsugoe S, Sueyoshi K, Aikou T, Sato E: Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol. 2000, 31: 428-433. 10.1053\/hp.2000.6534.","journal-title":"Hum Pathol"},{"key":"498_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1530\/eje.0.1490449","volume":"149","author":"RB Kov\u00e0cs","year":"2003","unstructured":"Kov\u00e0cs RB, F\u00f6ldes J, Winkler G, Bod\u00f3 M, S\u00e1pi Z: The investigation of galectin-3 in diseases of thyroid gland. Eur J Endocrinol. 2003, 149: 449-453. 10.1530\/eje.0.1490449.","journal-title":"Eur J Endocrinol"},{"key":"498_CR28","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(00)04817-0","volume":"357","author":"A Bartolazzi","year":"2001","unstructured":"Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O: Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 2001, 357: 1644-1650. 10.1016\/S0140-6736(00)04817-0.","journal-title":"Lancet"},{"key":"498_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1385\/EP:13:3:207","volume":"13","author":"S Erkili\u00e7","year":"2002","unstructured":"Erkili\u00e7 S, Aydin A, Ko\u00e7er NE: Diagnostic utility of cytokeratin 19 expression in multinodular goiter with papillary areas and papillary carcinoma of thyroid. Endocr Pathol. 2002, 13: 207-211. 10.1385\/EP:13:3:207.","journal-title":"Endocr Pathol"},{"key":"498_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF01324808","volume":"430","author":"E Fonseca","year":"1997","unstructured":"Fonseca E, Nesland JM, H\u00f6ie J, Sobrinho-Sim\u00f5es M: Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins. Virchows Arch. 1997, 430: 239-245. 10.1007\/BF01324808.","journal-title":"Virchows Arch"},{"key":"498_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2559.2004.01876.x","volume":"45","author":"ML Prasad","year":"2004","unstructured":"Prasad ML, Huang Y, Pellegata NS, de la Chapelle A, Kloos RT: Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC) - like nuclear alterations expresses molecular markers of PTC. Histopathology. 2004, 45: 39-46. 10.1111\/j.1365-2559.2004.01876.x.","journal-title":"Histopathology"},{"key":"498_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1365-2559.2006.02428.x","volume":"48","author":"ED Rossi","year":"2006","unstructured":"Rossi ED, Raffaelli M, Mule' A, Miraglia A, Lombardi CP, Vecchio FM, Fadda G: Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid. Histopathology. 2006, 48: 795-800. 10.1111\/j.1365-2559.2006.02428.x.","journal-title":"Histopathology"},{"key":"498_CR33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/ajcp\/92.5.654","volume":"92","author":"LJ Schelfhout","year":"1989","unstructured":"Schelfhout LJ, Van Muijen GN, Fleuren GJ: Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma. Am J Clin Pathol. 1989, 92: 654-658.","journal-title":"Am J Clin Pathol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-6-126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1746-1596-6-126\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-6-126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:04Z","timestamp":1548115204000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/1746-1596-6-126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1186\/1746-1596-6-126","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"article-number":"126"}}